In fact, as reported by KDIGO (Kidney Disease: Improving Global Outcomes), although rabbit anti-thymocyte globulin (rATG) is superior to anti-CD25 in high-risk transplant recipients, the potential risks of infection and malignancy outweigh these benefits in standard-risk recipients [30]. The gene discussed is IL2RA; the disease is infection.